30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q14 Revenue: Amedica

$5.8MM, +10% (U.S. $5.7MM, +11%; ex-U.S. $5K, -91%)

  • Silicon Nitride (SiNi) Ceramic Products $2.5MM, +41%
  • Non-SiNi $3.2MM, -6%


  • Ex-U.S. revenue decreased as company is focusing on domestic growth
  • Silicon Nitride growth primarily supported by launch of 2nd-generation Valeo interbody devices
  • ALIF, OLIF and PLIF products now launched; TLIF implant in beta launch
  • Ended 1Q with 7 direct field reps, ~50 independent distributors
  • Signed 12 new surgeons in 1Q